logo
科言猫学术研究的AI总结
language
手机端手机端
  • Phone Feature微信小程序
简体中文简体中文
notice消息通知
博客博客
delete
arrow
返回
S

Suzanne Lentzsch

columbia university medical center

58H指数
504论文数
1.8W被引数
收录论文 89
发表时间
logo
Emerging therapies and translational tools for drug development in systemic amyloidosis: insights from the International Society of Amyloidosis Scientific Workshop系统性淀粉样变性药物开发的 Emerging therapies and translational tools：来自国际淀粉样变性学会科学研讨会的见解
errAmyloid-Journal of Protein Folding Disorders
IF7.4
err2026-10-05
err0
PREAI
errGareth J. Morgan; Angela Dispenzieri; Jing Fu; Richard M. Giadone; Jeffery W. Kelly; Suzanne Lentzsch; Mathew S. Maurer; Stefano Ricagno; Christophe Sirac; Ashutosh D. Wechalekar
err分享
err收藏
A Clinically Applicable Conversion Formula between NT-proBNP and BNP in Light-Chain Amyloidosis轻链淀粉样变性中NT-proBNP与BNP之间临床适用的转换公式
errJACC: CardioOncology
IF12.8
err2026-07-20
err0
errOAAI
errEli Muchtar; Allan S. Jaffe; Andrew Staron; Vaishali Sanchorawala; Heather Landau; Oren Pasvolsky; Rajshekhar Chakraborty; Suzanne Lentzsch; Morie A. Gertz; Angela Dispenzieri
err分享
err收藏
Use of CD38 antibodies in high-risk newly diagnosed Multiple Myeloma – A meta-analysisCD38抗体在高危初诊多发性骨髓瘤中的应用——一项系统评价
errClinical Lymphoma Myeloma and Leukemia
IF2.7
err2026-04-30
err0
PREAI
errDivaya Bhutani; Yusha Liu; Rajshekhar Chakraborty; Michael Hughes; Suzanne Lentzsch; Samuel Rubinstein
err分享
err收藏
Phase 1/1b study of BCMA-targeting bispecific T-cell engager pavurutamab in relapsed/refractory multiple myelomaBCMA靶向双特异性T细胞接合剂pavurutamab在复发/难治性多发性骨髓瘤中的1/1b期研究
errBlood
IF23.1
err2026-04-09
err0
PREAI
errHans C. Lee; Wouter J. Plattel; Simon J. Harrison; Douglas W. Sborov; Suzanne Lentzsch; Andrew Spencer; Ruben Niesvizky; Suzanne Trudel; Peter Mollee; Ravi Vij; Monique C. Minnema; Leo Rasche; Vijay V. Upreti; Di Zhou; Qing Xia; Mihaela Talpes; Tobias Eggert; Prashant Kapoor; Sikander Ailawadhi
err分享
err收藏
Zanubrutinib in AL Amyloidosis Associated With Waldenström Macroglobulinemia and Other B-Cell Non-Hodgkin Lymphoma泽鲁布替尼在与华氏巨球蛋白血症及其他B细胞非霍奇金淋巴瘤相关的AL淀粉样变性中的应用
errAmerican Journal of Hematology
IF9.9
err2026-03-16
err0
errOAAI
errWouter Verhaar; Flores Weverling; Jahanzaib Khwaja; Despina Trajanova; Martine Chamuleau; Kirsty Cuthill; Shirley D’Sa; Paul A. F. Geerts; Kaz Groen; Troels Hammer; Marie José Kersten; Ida B. Kristensen; Suzanne Lentzsch; Sophie Bernelot Moens; Amy Song; Andre J. Vlot; Peter E. Westerweel; Ute Hegenbart; Stefan Schönland; Ashutosh Wechalekar; Monique C. Minnema; Josephine M. I. Vos
err分享
err收藏
Kinetics of hematologic response in AL amyloidosis: Insights from clinical and cytogenetic subgroup analysis in the daratumumab era
errHEMASPHERE
IF14.6
err2025-12-28
err0
errOAAI
errBazarbachi, Abdul-hamid; Zanwar, Saurabh; Hegenbart, Ute; Trajanova, Despina; Bhutani, Divaya; Gertz, Morie A.; Dispenzieri, Angela; Kumar, Shaji; D'souza, Anita; Patwari, Anannya; Cowan, Andrew; Chen, Guizhen; Milani, Paolo; Palladini, Giovanni; Sanchorawala, Vaishali; Bodanapu, Geethika; Mohty, Mohamad; Lentzsch, Suzanne; Schonland, Stefan O.; Muchtar, Eli; Chakraborty, Rajshekhar
err分享
err收藏
CAR T-cells in multiple myeloma: the race to the start lineCAR T细胞在多发性骨髓瘤中的应用：争夺起跑线的竞赛
errBone Marrow Transplantation
IF5.2
err2025-12-27
err0
PREAI
errAbdul-Hamid Bazarbachi; Divaya Bhutani; Michael Sang Hughes; Suzanne Lentzsch; Markus Mapara; Pawel Muranski; Ran Reshef; Tamna Wangjam; Rajshekhar Chakraborty
err分享
err收藏
Linvoseltamab in Patients with Relapsed/Refractory Multiple Myeloma in the LINKER-MM1 Study: Longer Follow-Up and Subgroup Analyses在LINKER-MM1研究中，复发/难治性多发性骨髓瘤患者的linvoseltamab治疗：更长时间的随访和亚组分析
errClinical Lymphoma Myeloma and Leukemia
IF2.7
err2025-11-12
err0
errOAAI
errHans C. Lee; Jeffrey A. Zonder; Madhav V. Dhodapkar; Sundar Jagannath; James E. Hoffman; Attaya Suvannasankha; Mansi R. Shah; Suzanne Lentzsch; Rachid Baz; Joseph J. Maly; Swathi Namburi; Matthew J. Pianko; Jing Christine Ye; Ka Lung Wu; Rebecca Silbermann; Chang-Ki Min; Marie-Christiane Vekemans; Markus Munder; Ja Min Byun; Joaquín Martínez-Lopez
err分享
err收藏
Talquetamab in relapsed refractory multiple myeloma: multi-institutional real-world studyTalquetamab在复发难治性多发性骨髓瘤中的应用：多中心真实世界研究
errBlood Cancer Journal
IF11.6
err2025-11-07
err0
errOAAI
errSamer Al Hadidi; Aniko Szabo; Bhavesh Mohan Lal; Aishee Bag; Simon Zhen; Yetunde Ogunsesan; Evanka Annyapu; Binod Dhakal; Divaya Bhutani; Sharmilan Thanendrarajan; Maurizio Zangari; Anita D’Souza; Suzanne Lentzsch; Frits van Rhee; Rajshekhar Chakraborty; Carolina Schinke; Meera Mohan; Mansi R. Shah
err分享
err收藏
Treatment response assessment using whole body diffusion weighted-magnetic resonance imaging in myeloma: a retrospective cohort study采用全身扩散加权磁共振成像评估骨髓瘤的治疗反应：一项回顾性队列研究
errLEUKEMIA & LYMPHOMA
IF2.2
err2025-11-01
err0
PREAI
errChakraborty, Rajshekhar; Shalaby, Khalid; Parker, Sarah; Lala, Sonali; Beylergil, Volkan; Alberico, Ronald; Bhutani, Divaya; Hillengass, Jens; Lentzsch, Suzanne
err分享
err收藏
Safety and efficacy of elranatamab in patients with daratumumab relapsed and/or refractory immunoglobulin light-chain amyloidosiselranatamab在daratumumab治疗复发和/或难治性免疫球蛋白轻链淀粉样变性患者中的安全性与有效性
errBlood
IF23.1
err2025-07-28
err0
PREAI
errPedro Vianna; Rajshekhar Chakraborty; Shahrier Hossain; Divaya Bhutani; Shannon Miller; Annemarie Rossi; Sarah A. M. Cuddy; Rodney H. Falk; Suzanne Lentzsch; Jacob P. Laubach; Giada Bianchi
err分享
err收藏
Long term follow-up of patients with AL amyloidosis treated on a phase 1 trial of CAEL-101AL淀粉样变性患者接受CAEL-101 1期临床试验治疗后的长期随访
errBlood Advances
IF7.1
err2025-07-19
err0
errOAAI
errMichael Sang Hughes; Samuel Pan; Rajshekhar Chakraborty; Jayant Raikhelkar; Mathew S. Maurer; Markus Y. Mapara; Andrew Eisenberger; Suzanne Lentzsch; Divaya Bhutani
err分享
err收藏
Optimizing Outcomes in Relapsed and Refractory Multiple Myeloma: Personalized Approaches and Adverse Event Management优化复发和难治性多发性骨髓瘤的结局：个性化方法及不良反应管理
errAMERICAN JOURNAL OF HEMATOLOGY
IF9.9
err2025-05-05
err0
PREAI
errKatodritou, E; Terpos, E; Lentzsch, S; Kumar, S
err分享
err收藏
Enhancing risk stratification and treatment decision in multiple myeloma with SKY92 gene expression profiling in real-world data利用SKY92基因表达谱分析真实世界数据，以提升多发性骨髓瘤的风险分层和治疗决策。
errBRITISH JOURNAL OF HAEMATOLOGY
IF3.8
err2025-04-15
err0
PREAI
errBiran, Noa; Dhakal, Binod; Niesvizky, Ruben; Lentzsch, Suzanne; Bhutani, Divaya; Mckay, John T.; Vesole, David H.; Nooka, Ajay; Paul, Barry; Hari, Parameswaran N.; D'Ambrosi, Silvia; Kuiper, Rowan; van Vliet, Martin; Siegel, David; Usmani, Saad Z.; van Rhee, Frits
err分享
err收藏
The Impact of Melphalan Conditioning and CD34+ Cell Dose and Schedule on Post-Transplant Outcomes in AL Amyloidosis美法仑预处理、CD34+细胞剂量及输注方案对AL型淀粉样变性移植后结局的影响
errAMERICAN JOURNAL OF HEMATOLOGY
IF9.9
err2025-04-11
err0
PREAI
errMuchtar, E; Sanchorawala, V; Hassan, H; Hegenbart, U; Schönland, S; Lee, HC; Qazilbash, M; Kin, A; Zonder, J; Jacob, E; Buadi, F; Dispenzieri, A; Dingli, D; Arai, S; Chin, M; Chakraborty, R; Lentzsch, S; Magen, H; Shkury, E; Sarubbi, C; Landau, H; Gertz, M
err分享
err收藏
Treatment Patterns and Clinical Outcomes of Patients With Systemic Light Chain Amyloidosis in the United States: Evidence From Real-World Clinical Practice系统性轻链淀粉样变性患者在美国的治疗模式与临床结局：来自真实世界临床实践的依据
errClinical Lymphoma Myeloma and Leukemia
IF2.7
err2025-03-28
err0
errOAAI
errSophia S. Li; Anita D'Souza; Suzanne Lentzsch; Faiza Zafar; Irina Pivneva; Talissa Watson; Annie Guerin; Shaji Kumar
err分享
err收藏
Primary systemic amyloidosis: A brief overview原发性系统性淀粉样变性: 简要概述
errPRESSE MEDICALE
IF3.4
err2025-03-01
err1
PREAI
errHughes, Michael Sang; Lentzsch, Suzanne
err分享
err收藏
The Undetermined Significance of Screening for Monoclonal Gammopathy of Undetermined Significance
errCANCER EPIDEMIOLOGY BIOMARKERS & PREVENTION
IF3.4
err2024-12-02
err0
PREAI
errQunaj, Lindor; Lentzsch, Suzanne; Neugut, Alfred I.
err分享
err收藏
Safety and Efficacy of SGLT2 Inhibitors for Amyloid Light-Chain Cardiomyopathy
errJOURNAL OF CARDIAC FAILURE
IF8.2
err2024-12-01
err2
PREAI
errLang, Frederick M.; Teruya, Sergio; Cuomo, Margaret; Santos, Alfonsina mirabal; Radhakrishnan, Jai; Lentzsch, Suzanne; Chakraborty, Rajshekhar; Bhutani, Divaya; Maurer, Mathew S.
err分享
err收藏
Spotlight: Smoldering Myeloma High-Risk Patient Observation and Longitudinal Insight Trial聚焦：冒烟型骨髓瘤高风险患者观察与纵向洞察试验
errBLOOD
IF23.1
err2024-11-05
err0
PREAI
errNuli, Sharmilee; Chakraborty, Rajshekhar; Abdallah, Al-Ola; Lentzsch, Suzanne; Ouchveridze, Evguenia; Sborov, Douglas W.; Godara, Amandeep; Mcclune, Brian; Jeong, Ah-Reum; Rubinstein, Samuel M.; Goodman, Aaron; Mohyuddin, Ghulam Rehman
err分享
err收藏

研究方向

暂时未获取到该数据
合作学者
合作期刊
K
Kenneth C. Anderson
H 指数: 199 · 论文数: 3.1K
P
Paul G. Richardson
H 指数: 170 · 论文数: 2.1K
S
S. Vincent Rajkumar
H 指数: 165 · 论文数: 1.9K
P
Philippe Moreau
H 指数: 159 · 论文数: 2.3K
M
Meletios Α. Dimopoulos
H 指数: 159 · 论文数: 3.0K
查看更多